Skip to main content
Top
Published in: Modern Rheumatology 5/2012

01-09-2012 | Original Article

Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis: comparison of the accuracy of plain MRI-based findings and gadolinium-diethylenetriamine pentaacetic acid-enhanced MRI-based findings

Authors: Mami Tamai, Atsushi Kawakami, Masataka Uetani, Aya Fukushima, Kazuhiko Arima, Keita Fujikawa, Naoki Iwamoto, Toshiyuki Aramaki, Makoto Kamachi, Hideki Nakamura, Hiroaki Ida, Tomoki Origuchi, Kiyoshi Aoyagi, Katsumi Eguchi

Published in: Modern Rheumatology | Issue 5/2012

Login to get access

Abstract

Objective

To explore whether synovitis and bone lesions in the wrists and finger joints visualized by plain magnetic resonance imaging (MRI)-based findings correspond exactly or not to those judged by gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced MRI-based findings.

Methods

Magnetic resonance imaging of the wrists and finger joints of both hands were examined in 51 early-stage rheumatoid arthritis (RA) patients whose median disease duration from the onset of articular manifestations to entry was 5 months, by both plain (T1 and short-time inversion recovery images) and Gd-DTPA-enhanced MRI (post-contrast fat-suppressed T1-weighted images) simultaneously. We focused on 15 sites per hand, to examine the presence of synovitis and bone lesions (bone edema and bone erosion). Gd-DTPA-enhanced MRI-based findings were considered “true” lesions, and we evaluated the accuracy of plain MRI-based findings in comparison to Gd-DTPA-enhanced MRI-based findings.

Results

Synovitis, judged by plain MRI-based findings, appeared as false-positive at pretty frequency; thus, the specificity, positive predictive value and accuracy of the findings were low. The rate of enhancement (E-rate) in false-positive synovitis sites was significantly low compared with true-positive synovitis sites where Gd-DTPA enhancement appears. In contrast to synovitis, the false-positivity of bone lesions, judged by plain MRI-based findings, was very low compared with Gd-DTPA-enhanced MRI-based findings.

Conclusion

Synovitis judged by plain MRI-based findings is sometimes considered false-positive especially in sites where synovitis is mild. However, plain MRI is effective in identifying bone lesions in the wrist and finger joints in early-stage RA.
Literature
1.
go back to reference Østergaard M, Pedersen SJ, Døhn UM. Imaging in rheumatoid arthritis: status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. Best Pract Res Clin Rheumatol. 2008;22:1019–44.PubMedCrossRef Østergaard M, Pedersen SJ, Døhn UM. Imaging in rheumatoid arthritis: status and recent advances for magnetic resonance imaging, ultrasonography, computed tomography and conventional radiography. Best Pract Res Clin Rheumatol. 2008;22:1019–44.PubMedCrossRef
2.
go back to reference Kubassova O, Boesen M, Peloschek P et al. Quantifying disease activity and damage by imaging in rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci. 2009;1154:207–38.PubMedCrossRef Kubassova O, Boesen M, Peloschek P et al. Quantifying disease activity and damage by imaging in rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci. 2009;1154:207–38.PubMedCrossRef
3.
go back to reference McQueen FM. The use of MRI in early RA. Rheumatology (Oxf). 2008;47:1597–9.CrossRef McQueen FM. The use of MRI in early RA. Rheumatology (Oxf). 2008;47:1597–9.CrossRef
4.
go back to reference McGonagle D, Tan AL. What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis: the first 50 years. Arthritis Res Ther. 2008;10:222.PubMedCrossRef McGonagle D, Tan AL. What magnetic resonance imaging has told us about the pathogenesis of rheumatoid arthritis: the first 50 years. Arthritis Res Ther. 2008;10:222.PubMedCrossRef
5.
go back to reference Tamai M, Kawakami A, Uetani M et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using MRI of wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009;61:772–8.PubMedCrossRef Tamai M, Kawakami A, Uetani M et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using MRI of wrists and finger joints and serologic autoantibodies. Arthritis Rheum. 2009;61:772–8.PubMedCrossRef
6.
go back to reference Tamai M, Kawakami A, Uetani M et al. Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis. J Rheumatol. 2007;34:2154–7.PubMed Tamai M, Kawakami A, Uetani M et al. Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis. J Rheumatol. 2007;34:2154–7.PubMed
7.
go back to reference Tamai M, Kawakami A, Uetani M et al. Early prediction of rheumatoid arthritis by serological variables and magnetic resonance imaging of the wrists and finger joints: results from prospective clinical examination. Ann Rheum Dis. 2006;65:134–5.PubMedCrossRef Tamai M, Kawakami A, Uetani M et al. Early prediction of rheumatoid arthritis by serological variables and magnetic resonance imaging of the wrists and finger joints: results from prospective clinical examination. Ann Rheum Dis. 2006;65:134–5.PubMedCrossRef
8.
go back to reference Tamai M, Kawakami A, Uetani M et al. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis. 2006;65:133–4.PubMedCrossRef Tamai M, Kawakami A, Uetani M et al. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis. 2006;65:133–4.PubMedCrossRef
9.
go back to reference Ersoy H, Rybicki FJ. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging. 2007;26:1190–7.PubMedCrossRef Ersoy H, Rybicki FJ. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging. 2007;26:1190–7.PubMedCrossRef
10.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.PubMedCrossRef
11.
go back to reference Fujikawa K, Kawakami A, Tamai M et al. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3 and MRI-proven bone erosion. J Rheumatol. 2009;36:1126–9.PubMedCrossRef Fujikawa K, Kawakami A, Tamai M et al. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3 and MRI-proven bone erosion. J Rheumatol. 2009;36:1126–9.PubMedCrossRef
12.
go back to reference Lassere M, McQueen F, Østergaard M et al. OMERACT Rheumatoid arthritis magnetic resonance imaging studies. Exercise 3: an international multicenter reliability study using the RA-MRI Score. J Rheumatol. 2003;30:1366–75.PubMed Lassere M, McQueen F, Østergaard M et al. OMERACT Rheumatoid arthritis magnetic resonance imaging studies. Exercise 3: an international multicenter reliability study using the RA-MRI Score. J Rheumatol. 2003;30:1366–75.PubMed
13.
go back to reference Conaghan P, Lassere M, Østergaard M, Peterfy C, McQueen F, O’Connor P et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 4: an international multicenter longitudinal study using the RA-MRI Score. J Rheumatol. 2003;30(6):1376–9.PubMed Conaghan P, Lassere M, Østergaard M, Peterfy C, McQueen F, O’Connor P et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 4: an international multicenter longitudinal study using the RA-MRI Score. J Rheumatol. 2003;30(6):1376–9.PubMed
14.
go back to reference Ostergaard M, Conaghan PG, O’Connor P, Szdudlarek M, Klarlund M, Emery P, et al. Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection—does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS? J Rheumatol. 2009;36:1806–10. (Erratum in: J Rheumatol. 2010;27:2198).PubMedCrossRef Ostergaard M, Conaghan PG, O’Connor P, Szdudlarek M, Klarlund M, Emery P, et al. Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection—does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS? J Rheumatol. 2009;36:1806–10. (Erratum in: J Rheumatol. 2010;27:2198).PubMedCrossRef
15.
go back to reference Cimmino MA, Innocenti S, Livrone F, Magnaguagno F, Silvestri E, Garlaschi G. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from in active disease. Arthritis Rheum. 2003;48(5):1207–13.PubMedCrossRef Cimmino MA, Innocenti S, Livrone F, Magnaguagno F, Silvestri E, Garlaschi G. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from in active disease. Arthritis Rheum. 2003;48(5):1207–13.PubMedCrossRef
Metadata
Title
Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis: comparison of the accuracy of plain MRI-based findings and gadolinium-diethylenetriamine pentaacetic acid-enhanced MRI-based findings
Authors
Mami Tamai
Atsushi Kawakami
Masataka Uetani
Aya Fukushima
Kazuhiko Arima
Keita Fujikawa
Naoki Iwamoto
Toshiyuki Aramaki
Makoto Kamachi
Hideki Nakamura
Hiroaki Ida
Tomoki Origuchi
Kiyoshi Aoyagi
Katsumi Eguchi
Publication date
01-09-2012
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 5/2012
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-011-0575-8

Other articles of this Issue 5/2012

Modern Rheumatology 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine